FDA Inspection
Prescript Pharmaceuticals, Inc.Prescript Pharmaceuticals, Inc. – FDA Inspection, Mar 3, 2011
Record Details
This FDA Inspection record concerns Prescript Pharmaceuticals, Inc., with an inspection on March 3, 2011, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- March 3, 2011
- Product Type
- Drugs
View Company Profile
ID · 59f2288f-f45c-43ff-a6ae-4ee61a9e25a3
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 711361
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Prescript Pharmaceuticals, Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| May 7, 2025 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 30, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 25, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 16, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 21, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Prescript Pharmaceuticals, Inc.
- FDA Inspection 1269790 - 2025-05-07
- FDA Inspection 1046277 - 2018-03-30
- FDA Inspection 873762 - 2014-03-25
- FDA Inspection 752730 - 2011-11-16
- FDA Inspection 598180 - 2009-07-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.